Immunoarchitectural patterns as potential prognostic factors for invasive ductal breast cancer

被引:6
|
作者
Du, Xue [1 ,2 ]
Zhou, Zhe [1 ]
Shao, Yun [2 ]
Qian, Kun [1 ]
Wu, Yongfang [2 ]
Zhang, Jun [2 ]
Cui, Miao [2 ]
Wang, Jingjing [2 ]
Wang, Shengqi [1 ]
Tai, Yanhong [2 ]
机构
[1] Beijing Inst Radiat Med, Beijing, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Dept Pathol, Med Ctr 5, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
TUMOR-INFILTRATING LYMPHOCYTES;
D O I
10.1038/s41523-022-00389-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Currently, tumor-infiltrating lymphocytes (TILs) in invasive breast cancers are assessed solely on the basis of their number, whereas their spatial distribution is rarely investigated. Therefore, we evaluated TILs in 579 patients with invasive breast cancer of no special type (IBC-NST) with a focus on their spatial distributions in tumor center (TC) and invasive margin (IM). We also assessed a new factor, namely para-tumor infiltrating lymphocytes (PILs) in the para-tumor lobular area (Para). Five immunoarchitectural patterns (IPs) were observed, which were significantly associated with clinicopathological features, especially molecular subtypes, histological grades, clinical stages, and programmed death-ligand 1 (PD-L1) expression. High-TIL density (IP1/2) correlated with favorable disease-free survival (DFS) in TNBC patients (p = 0.04), but opposite results were observed for luminal B subtype patients (both the lowest TIL and PIL densities (IP5) correlated with good DFS, p = 0.013). Luminal B patients with high TILs in the IM and low TILs in the TC (IP3) exhibited the worst DFS, whereas those with low TILs (similar to IP5) and high PILs (IP4) exhibited poor DFS. We also identified TIL subpopulations with significantly different IPs. Our findings suggest that IP can be a potential prognostic factor for tumor immunity in IBC.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer
    Kerlikowske, K
    Barclay, J
    Grady, D
    Sickles, EA
    Ernster, V
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (01): : 76 - 82
  • [22] RUNX2 Expression as a Potential Prognostic Marker in Invasive Ductal Breast Carcinoma
    El-Gendi, Saba
    Farouk, Mohamed
    LABORATORY INVESTIGATION, 2015, 95 : 43A - 43A
  • [23] Runx2 Expression as a Potential Prognostic Marker in Invasive Ductal Breast Carcinoma
    El-Gendi, Saba Mohamed
    Mostafa, Mohamed Farouk
    PATHOLOGY & ONCOLOGY RESEARCH, 2016, 22 (03) : 461 - 470
  • [24] RUNX2 Expression as a Potential Prognostic Marker in Invasive Ductal Breast Carcinoma
    El-Gendi, Saba
    Farouk, Mohamed
    MODERN PATHOLOGY, 2015, 28 : 43A - 43A
  • [25] Prognostic factors for patients with invasive ductal carcinoma of the breast who received neoadjuvant chemotherapy
    Tamura, N.
    BREAST, 2009, 18 : S33 - S33
  • [26] Prognostic factors for patients with invasive ductal carcinoma of the breast who received neoadjuvant chemotherapy
    Tamura, N.
    Tamura, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [27] Correlation of HER-2/neu protein overexpression with other prognostic and predictive factors in invasive ductal breast cancer
    Ivkovic-Kapicl, Tatjana
    Knezevic-Usaj, Slavica
    Djilas-Ivanovic, Dragana
    Panjkovic, Milana
    IN VIVO, 2007, 21 (04): : 673 - 678
  • [28] NEW PROGNOSTIC FACTORS IN INVASIVE BREAST-CANCER IN MEN
    GATTUSO, P
    REDDY, V
    GREEN, L
    CASTELLI, M
    WICK, M
    LABORATORY INVESTIGATION, 1992, 66 (01) : A13 - A13
  • [29] Invasive breast cancer and age-related prognostic factors
    di Rocco, R.
    Romiti, A.
    Amanti, C.
    Di Stefano, D.
    Renzi, C.
    Pasquini, P.
    Sarcina, I.
    Durante, V.
    D Antonio, C.
    Marchetti, P.
    ANNALS OF ONCOLOGY, 2007, 18 : 42 - 42
  • [30] THE RELATIVE PROGNOSTIC-SIGNIFICANCE OF NUCLEOLAR MORPHOMETRY IN INVASIVE DUCTAL BREAST-CANCER
    BAAK, JPA
    HISTOPATHOLOGY, 1985, 9 (04) : 437 - 444